Cover Image

The latency reversal activity of the SMAC mimetic AZD5582 in ART-suppressed SIV-infected rhesus macaques is potentiated by CD8a cell depletion

Saved in:

Bibliographic Details
Main Authors:	M. Mavigner (Author), A. Brooks (Author), C. Mattingly (Author), T. Vanderford (Author), B. Keele (Author), J. Lifson (Author), R. Dunham (Author), D. Margolis (Author), G. Silvestri (Author), A. Chahroudi (Author)
Format:	Book
Published:	Elsevier, 2019-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Evaluating latency reactivation synergies between the bromodomain inhibitor iBET-151 and the SMAC mimetic AZD5582 in SIV-infected macaques on ART
by: A.A. Okoye, et al.
Published: (2019)

CD8 depletion plus signaling of the non-canonical NF-kB pathway reverses latency in SIV-infected, ART-suppressed rhesus macaques
by: M. Mavigner, et al.
Published: (2019)

The SMAC mimetic AZD5582 reverses HIV latency as a single agent in resting primary CD4+ T cells
by: G. Sampey, et al.
Published: (2019)

PP 2.14 - 00162 Elucidating the effects of combination therapy with Venetoclax and IAP inhibitor AZD5582 in SIV-infected, ART-suppressed macaques
by: B. Ukhueduan, et al.
Published: (2022)

Clones of SIV-infected cells are present in spleen and lymph nodes in rhesus macaques
by: S.H. Hughes, et al.
Published: (2015)

OA4-5 LB SIV persistence in ART-treated infant rhesus macaques
by: M. Mavigner, et al.
Published: (2016)

Persistence of SIV in the brain of SIV-infected Chinese rhesus macaques with or without antiretroviral therapy
by: B. Ling, et al.
Published: (2017)

Virologic and immunologic correlates of viral control after ART-interruption in SIV-infected rhesus macaques
by: M. Paiardini, et al.
Published: (2015)

B cell depletion alone or in combination with IL-15 or PD-1 blockade facilitates enhanced control of virus replication in SIV-infected rhesus macaques
by: L.J. Picker, et al.
Published: (2019)

Oral TLR7 agonist administration induces an immunostimulatory response in SIV-infected ART-suppressed infant rhesus macaques
by: K. Bricker, et al.
Published: (2019)

21 T regulatory cell depletion in controller macaques reactivates SIV and boosts CTLs
by: T. He, et al.
Published: (2016)

SMAC mimetics are potent latency reversal agents with single agent and combination activity ex vivo
by: R.M. Dunham, et al.
Published: (2017)

Single-cell transcriptome of in vivo SIV-infected rhesus macaque CD4 T cells
by: A. Tokarev, et al.
Published: (2019)

SMAC mimetics reverse HIV latency by selective activation of the non-canonical NF-κB pathway
by: G.C. Sampey, et al.
Published: (2017)

Sustained SHIV reactivation by N-803 in ART-treated CD8-depleted macaques
by: J.B. McBrien, et al.
Published: (2019)

Different regimens of romidepsin administration for reversion of SIV latency in a rhesus macaque model of complete virus control
by: A. Kleinman, et al.
Published: (2019)

OA4-1 Combined IL-21 and IFNα treatment limits residual inflammation, viral persistence and delays viral rebound in SIV-infected rhesus macaques
by: L. Micci, et al.
Published: (2017)

Location, abundance and persistence of CAR/CXCR5 transduced T cells within lymphoid tissues of SIV-infected rhesus macaques
by: H. Abdelaal, et al.
Published: (2019)

PP 4.17 - 00198 Peripheral Blood Biomarkers of Occult Infection in ART-Suppressed, SIV-Infected Rhesus Macaques
by: M. Boudries, et al.
Published: (2022)

SIV/SHIV-Zika co-infection does not alter disease pathogenesis in adult non-pregnant rhesus macaque model.
by: Mehdi R M Bidokhti, et al.
Published: (2018)

Evaluation of IAP/SMAC mimetics as latency reversal agents in primary cells and cytokine induction in in vivo models predictive of cytokine release
by: B. Howell, et al.
Published: (2019)

Optimisation of Smac mimetics as HIV-1 latency reversing agents
by: L. Pache, et al.
Published: (2019)

Quantifying integrated SIV-DNA by repetitive-sampling Alu-gag PCR
by: Maud Mavigner, et al.
Published: (2016)

The TwistDock workflow for evaluation of bivalent Smac mimetics targeting XIAP
by: Huang Q, et al.
Published: (2019)

Overview of the progress and prospects of SMAC mimetics in cancers: Is it a silver bullet?
by: Almuradova Elvina, et al.
Published: (2022)

Multi-dose romidepsin in SIV-infected rhesus macaques (RMs) reactivates latent, replication-competent virus in the absence of antiretroviral therapy (ART)
by: B. Policicchio
Published: (2015)

Partial control of viral rebound with a Rev-dependent lentiviral vector carrying HSV-tk gene in SIV-infected rhesus macaques
by: Y. Wu, et al.
Published: (2017)

PP 8.1 - 00003 Optimization of the 5' cap and untranslated regions enhances the immunogenicity of an mRNA-based therapeutic vaccine in SIV-infected rhesus macaques on ART
by: W. Omange, et al.
Published: (2022)

Targeting apoptotic machinery as approach for anticancer therapy: Smac mimetics as anticancer agents
by: Nevine M.Y. Elsayed, et al.
Published: (2015)

PP 2.1 - 00014 Impact of early antiretroviral therapy on tissue resident myeloid cells in the liver and lung of SIV-infected rhesus macaques
by: J. Clain, et al.
Published: (2022)

PP 2.11 - 00144 Transcriptional and translational SIV profiles of peripheral and lymphoid CD4+ T cells of viremic and ART-suppressed Rhesus macaques
by: M. Nayrac, et al.
Published: (2022)

PP 8.13 - 00191 Investigating the Impact of CD4 mimetic BNM-III-170 on SHIV-infected Rhesus Macaques
by: E. Viox, et al.
Published: (2022)

Assisted reproductive technologies in rhesus macaques
by: Wolf Don P
Published: (2004)

PP 2.15 - 00169 Macrophages are the primary source of virus in semen and male genital tract organs in acutely and chronically infected rhesus macaques
by: C. Deleage, et al.
Published: (2022)

Dimethyl Fumarate, an Approved Multiple Sclerosis Treatment, Reduces Brain Oxidative Stress in SIV-Infected Rhesus Macaques: Potential Therapeutic Repurposing for HIV Neuroprotection
by: Yoelvis Garcia-Mesa, et al.
Published: (2021)

The SMAC Mimetic APG-1387 Sensitizes Immune-Mediated Cell Apoptosis in Hepatocellular Carcinoma
by: Zide Chen, et al.
Published: (2018)

Mayaro virus pathogenesis and immunity in rhesus macaques.
by: Whitney C Weber, et al.
Published: (2023)

OP 8.4 - 00165 TLR agonist and SIV mAbs administered to SIV-infected ART-suppressed macaques did not delay rebound after treatment interruption
by: H. King, et al.
Published: (2022)

SIV persists in lymphoid tissues despite alemtuzumab-induced CD4+ T cell depletion
by: A.A. Okoye, et al.
Published: (2017)

PP 5.4 - 00184 Optimization of Smac Mimetics as HIV-1 Latency Reversing Agents
by: L. Pache, et al.
Published: (2022)